Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
     
þ   Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 2010
     
o   Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from _______________ to _______________
Commission file number: 001-33304
Converted Organics Inc.
(Exact name of registrant as specified in its charter)
     
Delaware   20-4075963
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
137A Lewis Wharf, Boston, MA 02110
(Address of principal executive offices) (Zip Code)
(617) 624-0111
(Registrant’s telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES þ    NO o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES o    NO o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
             
Large accelerated filer o   Accelerated filer o   Non-accelerated filer o   Smaller reporting company þ
        (Do not check if a smaller reporting company)    
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES o NO þ
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: As of November 15, 2010, there were 56,721,249 shares of our common stock outstanding.
 
 

 


 

INDEX
         
    Page No.  
       
       
    3  
    4  
    5  
    6  
    7  
    19  
    26  
    26  
    26  
    26  
    27  
    27  
    27  
    27  
    27  
  EX-31.1
  EX-31.2
  EX-32.1
  EX-32.2
  EX-99.1

2


Table of Contents

Item 1. Financial Statements
CONVERTED ORGANICS INC.
CONSOLIDATED BALANCE SHEETS
                 
    September 30, 2010        
    (Unaudited)     December 31, 2009  
ASSETS
 
               
CURRENT ASSETS
               
Cash
  $ 483,068     $ 10,708,807  
Restricted cash
    613,295       613,162  
Accounts receivable, net
    414,824       80,911  
Inventories
    110,915       176,351  
Other prepaid expenses
    53,406       73,194  
Assets of discontinued operations
    2,598,230       962,075  
 
           
Total current assets
    4,273,738       12,614,500  
 
           
 
               
Deposits
    336,357       336,357  
Other assets
    500,000        
Property and equipment, net
    676,260       691,694  
Construction-in-progress
    357,118       311,015  
Intangible assets, net
    1,779,613       1,995,619  
Non-current assets of discontinued operations
    1,271,158       19,193,886  
 
           
Total assets
  $ 9,194,244     $ 35,143,071  
 
           
 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)
 
               
CURRENT LIABILITIES
               
Accounts payable
  $ 1,294,798     $ 552,057  
Accrued compensation, officers, directors and consultants
    513,745       697,602  
 
               
Accrued legal and other expenses
    216,914       136,153  
Accrued interest
          9,448  
Convertible note payable
          355,164  
Liabilities of discontinued operations
    6,047,844       4,475,303  
 
           
Total current liabilities
    8,073,301       6,225,727  
 
           
 
               
Derivative liabilities
    1,434,127       1,626,742  
Convertible note payable, net of current portion
          17,767  
Non-current liabilities of discontinued operations
    17,531,311       18,501,081  
 
           
Total liabilities
    27,038,739       26,371,317  
 
           
 
               
COMMITMENTS AND CONTINGENCIES
           
 
               
SHAREHOLDERS’ EQUITY (DEFICIT)
               
Preferred stock, $.0001 par value, authorized 10,000,000 shares; no shares issued and outstanding
           
Common stock, $.0001 par value, authorized 250,000,000 shares at September 30, 2010 and 75,000,000 shares at December 31, 2009
    4,414       3,777  
Additional paid-in capital
    63,662,679       58,660,042  
Accumulated deficit
    (81,511,588 )     (49,892,065 )
 
           
Total shareholders’ equity (deficit)
    (17,844,495 )     8,771,754  
 
           
Total liabilities and shareholders’ equity (deficit)
  $ 9,194,244     $ 35,143,071  
 
           
The accompanying notes are an integral part of these consolidated financial statements.

3


Table of Contents

CONVERTED ORGANICS INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
                                 
    Three month periods ended     Nine month periods ended  
    September 30, 2010     September 30, 2009     September 30, 2010     September 30, 2009  
Revenues
  $ 808,582     $ 694,123     $ 2,765,641     $ 1,801,046  
 
                               
Cost of goods sold
    583,703       608,882       2,020,752       1,773,785  
 
                       
 
                               
Gross income
    224,879       85,241       744,889       27,261  
 
                               
Operating expenses
                               
General and administrative expenses
    4,011,974       1,514,739       10,413,049       5,061,205  
Research and development
    35,000       87,500       176,650       267,000  
Amortization of capitalized costs
    72,001       72,002       216,006       228,709  
 
                       
 
    4,118,975       1,674,241       10,805,705       5,556,914  
 
                       
 
                               
Loss from continuing operations
    (3,894,096 )     (1,589,000 )     (10,060,816 )     (5,529,653 )
 
                       
 
                               
Other income/(expenses)
                               
Other income
    7,339             7,871       21,785  
Derivative gain/(loss)
    661,982       (241,448 )     1,160,711       4,056,997  
Interest expense
    (4,627 )     (726,227 )     (15,883 )     (4,029,446 )
 
                       
 
    664,694       (967,675 )     1,152,699       49,336  
 
                       
 
                               
Loss from continuing operations before provision for income taxes
    (3,229,402 )     (2,556,675 )     (8,908,117 )     (5,480,317 )
 
                               
Provision for income taxes
                       
 
                       
 
                               
Net loss from continuing operations
    (3,229,402 )     (2,556,675 )     (8,908,117 )     (5,480,317 )
 
                               
Loss from discontinued operations
    (18,685,007 )     (2,253,613 )     (22,711,406 )     (6,443,121 )
 
                       
 
                               
Net loss
  $ (21,914,409 )   $ (4,810,288 )   $ (31,619,523 )   $ (11,923,438 )
 
                       
 
                               
 
                               
Net loss per share, basic and diluted
                               
Continuing operations
  $ (0.07 )   $ (0.13 )   $ (0.22 )   $ (0.37 )
Discontinued operations
    (0.43 )     (0.11 )     (0.56 )     (0.44 )
 
                       
 
  $ (0.50 )   $ (0.24 )   $ (0.78 )   $ (0.81 )
 
                       
 
                               
Weighted average common shares outstanding
    43,187,437       20,065,306       40,354,562       14,708,633  
 
                       
The accompanying notes are an integral part of these consolidated financial statements.

4


Table of Contents

CONVERTED ORGANICS INC.
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)
FOR THE NINE MONTH PERIOD ENDED SEPTEMBER 30, 2010
(UNAUDITED)
                                         
    Common Stock                     Total  
    Shares Issued and             Additional     Accumulated     Owners’ Equity  
    Outstanding     Amount     Paid-in Capital     Deficit     (Deficit)  
Balance, December 31, 2009
    37,774,208     $ 3,777     $ 58,660,042     $ (49,892,065 )   $ 8,771,754  
Stock options
                1,305,812             1,305,812  
Common stock issued upon conversion of convertible notes payable and accrued interest
    645,500       65       413,894             413,959  
Common stock issued as compensation
    485,830       49       349,590             349,639  
Issuance of common stock and warrants, net of fair value of derivatives issued of $968,096
    2,400,000       240       1,398,024             1,398,264  
Issuance of common stock and warrants as payment of accounts payable
    2,780,740       278       1,501,322             1,501,600  
Common stock issued upon exercise of employee stock options
    50,000       5       33,995             34,000  
Net loss
                      (31,619,523 )     (31,619,523 )
 
                             
Balance, September 30, 2010
    44,136,278     $ 4,414     $ 63,662,679     $ (81,511,588 )   $ (17,844,495 )
 
                             
The accompanying notes are an integral part of these consolidated financial statements.

5


Table of Contents

CONVERTED ORGANICS INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
                 
    Nine month periods ended  
    September 30, 2010     September 30, 2009  
CASH FLOWS FROM OPERATING ACTIVITIES:
               
Net loss
  $ (31,619,523 )   $ (11,923,438 )
Adjustments to reconcile net loss to net cash used in operating activities:
               
Deconsolidation of variable interest entity
          (596,170 )
Amortization of intangible assets — license
    25,645       12,375  
Amortization of capitalized bond costs
    35,751       35,752  
Amortization of deferred financing fees
          22,042  
Amortization of intangible assets
    190,361       206,667  
Depreciation of fixed assets
    1,394,249       1,559,960  
Beneficial conversion feature
          230,492  
Amortization of discounts attributable to warrants on private financing
          1,458,647  
Non-cash interest expense — private financing
          1,245,186  
Common stock issued for extension of convertible note payable
          562,000  
Common stock issued as compensation
    349,639       120,313  
Stock option compensation expense
    1,305,812       190,022  
Warrants issued in connection with private financing and equity transactions
          662,479  
Loss on impairment of long-term assets
    15,430,685        
Derivative gain
    (1,160,711 )     (4,056,997 )
Changes in operating assets and liabilities:
               
(Increase) decrease in:
               
Accounts receivable
    (567,244 )     (61,659 )
Inventories
    337,833       (174,554 )
Prepaid expenses and other current assets
    (129,024 )     (217,605 )
Other assets
          94,250  
Deposits
    (48,240 )     165,122  
Increase (decrease) in:
               
Accounts payable and other accrued expenses
    4,217,011       3,157,897  
Accrued compensation — officers, directors and consultants
    (255,311 )     (86,802 )
Accrued interest
    362,658       (181,018 )
Other
          (53,955 )
 
           
Net cash used in operating activities
    (10,130,409 )     (7,628,994 )
 
           
 
               
CASH FLOWS FROM INVESTING ACTIVITIES:
               
Purchase of fixed assets
    (400,827 )     (3,623,823 )
Release of restricted cash
          2,578,338  
Construction costs
    (46,103 )     (54,081 )
Other assets
    (500,000 )      
 
           
Net cash used in investing activities
    (946,930 )     (1,099,566 )
 
           
 
               
CASH FLOWS FROM FINANCING ACTIVITIES:
               
Repayment of term notes
    (1,540,009 )     (243,956 )
Repayment of capital lease obligations
    (8,751 )     (9,614 )
Member’s contributions
          230,983  
Member’s distributions
          (201,630 )
Net proceeds from exercise of options
    34,000        
Net proceeds from stock offering
    2,366,360       3,806,272  
Net proceeds from exercise of warrants
          1,965,000  
Net proceeds from nonconvertible short-term note
          1,182,500  
Net proceeds from convertible short-term note
          1,400,000  
Repayment of nonconvertible short-term note
          (1,330,313 )
Repayment of mortgage payable
          (943 )
 
           
Net cash provided by financing activities
    851,600       6,798,299  
 
           
 
               
NET DECREASE IN CASH
    (10,225,739 )     (1,930,261 )
 
               
Cash, beginning of period
    10,708,807       3,357,940  
 
           
Cash, end of period
  $ 483,068     $ 1,427,679  
 
           
 
               
Supplemental cash flow information:
               
Cash paid during the period for:
               
Interest
  $ 808,679     $ 1,587,253  
 
               
Non-cash financing activities:
               
Equipment acquired through assumption of capital lease
  $     $ 52,979  
Equipment acquired through assumption of term note
          118,250  
Common stock issued upon conversion of convertible notes payable and accrued interest
    413,959       6,323,095  
Fair value of derivative issued
    968,096       3,827,686  
Common stock and warrants issued as payment for accounts payable
    1,501,600        
Discount on warrants issued in connection with financings
          2,870,313  
Member’s contribution of convertible note
          684,668  
Conversion of accounts payable into notes payable
          2,634,039  
The accompanying notes are an integral part of these consolidated financial statements.

6


Table of Contents

CONVERTED ORGANICS INC.
NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS (UNAUDITED)
NOTE 1 — BASIS OF PRESENTATION AND NATURE OF OPERATIONS
     The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. Certain information and footnote disclosures normally included in the annual financial statements of Converted Organics Inc. (the “Company”) have been condensed or omitted. In the Company’s opinion, the unaudited interim consolidated financial statements and accompanying notes reflect all adjustments, consisting of normal and recurring adjustments, that are necessary for a fair presentation of its financial position and operating results as of and for the three and nine month interim periods ended September 30, 2010 and 2009.
     The results of operations for the interim periods are not necessarily indicative of the results to be expected for the entire year. This Form 10-Q should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Form 10-K as of and for the year ended December 31, 2009.
NATURE OF OPERATIONS
     Converted Organics Inc. uses food and other waste as a raw material to manufacture, sell and distribute all-natural fertilizer products with nutrition characteristics which have been shown to support disease suppression. The Company generates revenues from two sources: product sales and tip fees. Product sales revenue comes from the sale of fertilizer products. Tip fee revenue is derived from waste haulers who pay the Company “tip” fees for accepting food waste generated by food distributors such as grocery stores, produce docks and fish markets, food processors and hospitality venues such as hotels, restaurants, convention centers and airports.
     Converted Organics of California, LLC, a California limited liability company and wholly-owned subsidiary of the Company, which operates the Company’s facility in Gonzales, California (the “Gonzales facility”) was formed when the Company acquired the assets of United Organics Products, LLC (“UOP”) and Waste Recovery Industries, LLC (“WRI”). The Gonzales facility produces approximately 25 tons of organic fertilizer per day, which is sold primarily to the California agricultural market. The Gonzales facility employs a proprietary method called High Temperature Liquid Composting (“HTLC”). The Gonzales facility has been upgraded to enable it to accept larger amounts of food waste from waste haulers and may be further upgraded, depending on demand, to have the capability to produce a dry product in addition to the current liquid fertilizer it produces.
     Converted Organics of Woodbridge, LLC, is a New Jersey limited liability company and wholly-owned subsidiary of the Company, which was formed for the purpose of owning, constructing and operating the Company’s facility in Woodbridge, New Jersey (the “Woodbridge facility”). The Woodbridge facility was designed to service the New York-Northern New Jersey metropolitan area. On July 30, 2010, the Company temporarily halted production at its Woodbridge facility in order to undertake steps to lower its cost structure at the Woodbridge facility. Specifically the Company attempted to negotiate more favorable terms under its operating lease and to lower certain utility costs. The Company was unable to lower such costs and therefore, management determined that the Company could not sustain the negative cash flow from the Woodbridge facility and discontinued operations at the Woodbridge plant. The Company has reported the results of operations of Converted Organics of Woodbridge, LLC as discontinued operations for the three and nine month periods ended September 30, 2010 and 2009 within the consolidated financial statements (See Note 4).
     Converted Organics of Rhode Island, LLC, a Rhode Island limited liability company and subsidiary of the Company, was formed in July 2008 for the purpose of developing a facility at the Rhode Island central landfill. Converted Organics of Rhode Island, LLC has not had any activity since its formation. On February 25, 2010, the Company signed a letter of intent with the owners of the non-controlling interest in Converted Organics of Rhode Island, LLC to sell substantially all of its assets and a limited select amount of liabilities, and assign the Company’s lease with the Rhode Island Resource Recovery Corporation (“RIRRC”).
     On January 26, 2010, the Company formed Converted Organics of Mississippi, LLC, a Mississippi limited liability company and a wholly-owned subsidiary of the Company, for the purpose of hiring a sales force and adding a poultry litter-based fertilizer product to the Company’s existing product lines. The Company outsources production of this product.
     On February 25, 2010, the Company signed a memorandum of understanding with MassOrganics I, under which MassOrganics I would operate the new manufacturing facility to be constructed at the Sutton Commerce Park in Sutton, Massachusetts. MassOrganics I has agreed to enter into a license agreement under which MassOrganics I will pay a licensing fee to the Company.

7


Table of Contents

CONVERTED ORGANICS INC.
NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS — CONTINUED

(UNAUDITED)
NOTE 1 — BASIS OF PRESENTATION AND NATURE OF OPERATIONS
NATURE OF OPERATIONS (Continued)
     On May 20, 2010, the Company formed TerraSphere Inc., a Delaware corporation and a wholly-owned subsidiary of the Company, for the purpose of acquiring TerraSphere Systems LLC.
     On July 6, 2010, a membership interest purchase agreement was entered into by TerraSphere, Inc., TerraSphere Systems LLC (“TerraSphere”) and the members of TerraSphere, pursuant to which the Company agreed to acquire 100% of the membership interests of TerraSphere. Pursuant to the purchase agreement, which was approved by the Company’s stockholders at a special meeting held on September 16, 2010, the Company could issue up to 34,166,667 shares of its common stock to the members of TerraSphere in exchange for 100% of the membership interest of TerraSphere, subject to certain anti-dilution adjustments. On November 12, 2010, the Company acquired 95% of the membership interest of TerraSphere. Pursuant to the purchase agreement, 18,174,603 shares were issued at the closing and the remainder of the shares will be issued if TerraSphere achieves certain milestones (See Note 12). TerraSphere designs, builds and operates highly efficient and scalable systems, featuring a patented, proprietary technology that utilizes vertically-stacked modules to house rows of plants, which are then placed perpendicular to an interior light source to grow pesticide-free, organic fruits and vegetables. Due to a controlled, indoor environment, the system generates fresh produce year-round in any location or climate world-wide.
     Mr. Edward J. Gildea, the Company’s Chairman and Chief Executive Officer, had an 8.75% membership interest in TerraSphere, and family members of Mr. Gildea held significant units of TerraSphere and served as officers of TerraSphere.
SEGMENTS
     On March 23, 2010, the Company entered into a loan and license agreement with Heartland Technology Partners, LLC (“HTP”). In consideration for entering the loan agreement, the Company was granted an exclusive, irrevocable license to utilize HTP’s patented LM-HT(TM) Concentrator technology in the U.S. industrial wastewater (IWW) market. The IWW market involves the treatment of waters that have been contaminated by anthropogenic industrial or commercial activities, prior to their reuse or release into the environment. The Company has begun to develop plans to operate its Industrial Wastewater Resources division. On July 30, 2010, the Company signed a letter of intent with Spirit Services, Inc. to jointly develop an energy and IWW treatment facility using the exclusively licensed technology to evaporate IWW at a facility in South Boston, Virginia. The segment is in the developmental stage and there is no discreet financial information to report at September 30, 2010.
RECLASSIFICATION
     As a result of the Woodbridge Facility operations being discontinued during the quarter ended September 30, 2010, the comparative periods have been reclassified to conform with the current quarter presentation. These reclassifications have no affect on previously reported net income, specifically, the Company has reclassified certain items as discontinued operations.
NOTE 2 — MANAGEMENT’S PLAN OF OPERATION
     On July 30, 2010 the Company announced a 50% reduction of its work force which included employees at the corporate level and the Woodbridge facility (the “restructuring”). The Company expects those salary reductions to save approximately $2.1 million over the next twelve months. The Company recorded restructuring charges totaling approximately $313,000 during the quarter ended September 30, 2010 and is included in general and administrative expense on the consolidated statements of operations. In addition on July 30, 2010, the Company temporarily halted production at its Woodbridge facility in order to undertake steps to lower its cost structure at the Woodbridge facility. Specifically the Company attempted to negotiate more favorable terms under its operating lease and to lower certain utility costs. The Company was unable to lower such costs and therefore, management determined that the Company could not sustain the negative cash flow from the Woodbridge facility and discontinued operations at the Woodbridge plant.

8


Table of Contents

CONVERTED ORGANICS INC.
NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS — CONTINUED

(UNAUDITED)
NOTE 2 — MANAGEMENT’S PLAN OF OPERATION (Continued)
     The Company currently has manufacturing capabilities at its Gonzales facility. The Gonzales facility is cash flow positive and is currently producing at approximately 60% of its capacity. The Company is focusing its current sales efforts on taking advantage of the additional production capacity. The additional production capacity could produce approximately $175,000 of additional positive cash flow a month. Previously, the Company estimated its negative cash flow requirements on a monthly basis were approximately $400,000 at the corporate level. The Company estimates that the current cost reduction efforts will lower the monthly cash flow requirements at the corporate level to $150,000. If the Company is unable to increase sales levels at Gonzales to offset the corporate level cash flow requirement, the Company will need to seek additional financing.
     On July 6, 2010, the Company reached an agreement to acquire TerraSphere Systems LLC (Note 1). The transaction was approved by the Company’s stockholders on September 16, 2010. The closing of the transaction acquiring 95% of TerraSphere was finalized on November 12, 2010 (See Note 12). The Company anticipates there will be cash available to the Company from the acquired entity. Any cash acquired by the Company would reduce amounts that otherwise need to be raised through a financing.
     The Company believes the restructuring and the discontinued operations of the Woodbridge facility and increased capacity utilization in Gonzales will allow the Company to pursue growth by developing its industrial wastewater business and developing the recent TerraSphere acquisition. Increasing capacity utilization at the Gonzales facility would result in additional positive cash flow without the need to fund an expansion at the facility. The Company is focusing its current sales efforts on taking advantage of the additional production capacity. The Company may require additional financing until the Company achieves the desired production capacity and sales levels and assuming it does not encounter additional costs or expenses, either unforeseen or resulting from any proposed mergers and/or acquisitions. To date, the Company has not achieved the desired sales levels required to offset the corporate level cash requirements. Therefore, the Company may require additional financing prior to achieving cash flow from operations for which it has no commitments.
     On July 2, 2010, a shelf registration statement was filed on Form S-3 to register $75,000,000 of common stock, which was declared effective on July 15, 2010. There is no assurance that capital in any form will be available to the Company, and if available, on terms and conditions that are acceptable.
NOTE 3 — NEWLY ADOPTED ACCOUNTING STANDARDS
     There are no new accounting standards significantly affecting the Company in the three and nine month periods ended September 30, 2010.
NOTE 4 — DISCONTINUED OPERATIONS
     On July 30, 2010, the Company temporarily halted production at its Woodbridge facility in order to undertake steps to lower its cost structure at the Woodbridge facility. Specifically the Company attempted to negotiate more favorable terms under its operating lease and to lower certain utility costs. The Company was unable to lower such costs and therefore, management determined that the Company could not sustain the negative cash flow from the Woodbridge facility and discontinued operations at the Woodbridge plant during the third quarter ended September 30, 2010. On October 18, 2010, the Company entered into a Termination and Surrender Agreement with the Woodbridge facility’s landlord (“Lessor”) transferring all equipment, tools and fixtures owned by the Company to the Lessor in lieu of its obligations to the Lessor (See Note 12). As a result, the Company impaired the Woodbridge facility’s assets to reduce the carrying value to approximately $1.5 million, which is the value expected to be received from the sale of those assets. The consolidated statements of operations includes an impairment charge of approximately $15.4 million for the three and nine month periods ended September 30, 2010 in loss from discontinued operations.
     The following table provides the revenue and loss from the Woodbridge Facility discontinued operations:
                                 
    For the three months ended     For the nine months ended  
    September 30,     September 30,  
    2010     2009     2010     2009  
Revenue from discontinued operations
  $ 105,714     $ 53,123     $ 834,089     $ 430,403  
Loss from discontinued operations
  $ (18,685,007 )   $ (2,253,613 )   $ (22,711,406 )   $ (6,443,121 )

9


Table of Contents

CONVERTED ORGANICS INC.
NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS — CONTINUED

(UNAUDITED)
NOTE 4 — DISCONTINUED OPERATIONS (Continued)
     The Company does not expect to have any continuing cash flows from the Woodbridge facility.
     The following table provides the assets and liabilities of the Woodbridge Facility, classified as discontinued operations, in the consolidated balance sheets dated September 30, 2010 and December 31, 2009:
                 
    2010     2009  
Accounts receivable
  $ 293,077     $ 59,746  
Inventory
          272,396  
Prepaid expenses
    778,610       629,933  
Property and equipment
    1,526,543       17,935,216  
Other assets
    1,271,158       1,258,670  
 
           
Assets of discontinued operations
  $ 3,869,388     $ 20,155,961  
 
           
 
               
Term notes payable
  $ 1,707,743     $ 3,247,752  
Accounts payable
    1,964,459       1,237,275  
Accrued expenses
    2,375,129       950,782  
Other liabilities
    31,824       40,575  
Bonds payable
    17,500,000       17,500,000  
 
           
Liabilities of discontinued operations
  $ 23,579,155     $ 22,976,384  
 
           
     On October 18, 2010, the Company entered into a series of transactions whereby assets of discontinued operations totaling approximately $3,500,000 and liabilities of discontinued operations totaling approximately $22,600,000 at September 30, 2010 were assigned, transferred and or extinguished (See Note 12).
     At September 30, 2010, assets of discontinued operations totaling $1,526,147 were classified as held for sale. The assets held for sale consist of the Woodbridge facility’s property and equipment. These assets were transferred to the Lessor on October 18, 2010 to satisfy certain obligations (see Note 12). No gain or loss was recognized on the sale.
NOTE 5 — INVENTORIES
     The Company’s inventories consisted of the following at September 30, 2010 and December 31, 2009:
                 
    2010     2009  
Finished goods
  $ 69,041     $ 137,027  
Raw materials
    41,874       39,324  
 
           
Total inventories
  $ 110,915     $ 176,351  
 
           

10


Table of Contents

CONVERTED ORGANICS INC.
NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS — CONTINUED

(UNAUDITED)
NOTE 6 — DEBT
TERM NOTES
     The Company entered into a financing agreement with an equipment financing company to acquire equipment for its Woodbridge facility. The note is for $118,250, bears an imputed interest rate of 9% and has a three year term, maturing January 2012. The outstanding balance of the equipment term note was approximately $50,000 and $71,000 at September 30, 2010 and December 31, 2009, respectively.
     During 2009, the Company agreed to convert certain accounts payable totaling approximately $2,634,000, related to the construction of the Woodbridge facility (the “construction term notes”), into term notes ranging from 12 to 24 months at various rates ranging from 0% to 9% with payment terms maturing through September 2011. The Company has recorded a discount on certain of the notes representing imputed interest of approximately $54,000, which is being amortized during the non-interest bearing period of the notes. The outstanding balance of these term notes was approximately $1,660,000 and $3,176,000 at September 30, 2010 and December 31, 2009. On October 18, 2010, the construction term notes were extinguished (See Note 12).
     The above term notes are classified in the current and non-current liabilities of discontinued operations on the consolidated balance sheets at September 30, 2010 and December 31, 2009.
CONVERTIBLE NOTE PAYABLE
     During the nine month period ended September 30, 2010, the Company issued 645,500 shares of common stock representing principal and interest payments of approximately $414,000 in satisfaction of its convertible debt obligation issued in connection with the acquisition of UOP and WRI.
BOND FINANCING
     On February 16, 2007, concurrent with its initial public offering, the Company’s wholly-owned subsidiary, Converted Organics of Woodbridge (“Woodbridge”), completed the sale of $17,500,000 of New Jersey Economic Development Authority Bonds (the “Bonds”). The Bonds carried a stated interest rate of 8% and were set to mature on August 1, 2027. The Bonds are classified in the liabilities of discontinued operations on the consolidated balance sheets at September 30, 2010 and December 31, 2009. On October 18, 2010, the Bonds payable were settled and extinguished (See Note 12).
NOTE 7 — DERIVATIVE INSTRUMENTS
     On May 7, 2009, in connection with notes issued pursuant to a financing agreement an investor received five-year warrants to purchase 750,000 shares and 350,000 shares of Company common stock, with an original exercise price of $1.00 per share and $1.50 per share, respectively, (Class C and D warrants, respectively) subject to certain anti-dilution provisions. The placement agent used for the offering was issued 135,000 Class C warrants and 65,000 Class D warrants. These warrants are subject to certain anti-dilution rights for issuance below the exercise prices and are not registered and cannot be traded. The exercise price for the Class C and D warrants are $1.00 per share and $1.02 per share, respectively, at September 30, 2010. The Company has determined that the warrant provisions providing for protection for issuances below the warrant exercise prices could result in modification of the exercise price based on a variable that is not an input to the fair value for a fixed-for-fixed option. Therefore, the Company determined the warrants issued in connection with this financing are a derivative instrument which is subject to mark-to-market adjustment each reporting period. At December 31, 2009, the fair value of the warrants was determined using a Black-Scholes model with the following assumptions: risk-free interest rate of 2.35%; no dividend yield; volatility of 98.6% resulting in a derivative liability of approximately $563,500. The liability was revalued as of September 30, 2010 using a Black-Scholes model and the following assumptions: risk-free interest rate of 1.27%; no dividend yield; and volatility of 122.3%, resulting in a revalued liability of approximately $359,000 and a derivative gain of approximately $173,000 and $205,000 on the consolidated statements of operations for the three and nine month periods ended September 30, 2010, respectively.

11


Table of Contents

CONVERTED ORGANICS INC.
NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS — CONTINUED

(UNAUDITED)
NOTE 7 — DERIVATIVE INSTRUMENTS (Continued)
     On September 8, 2009, in connection with notes issued pursuant to a financing agreement on that date, an investor received a five-year warrant to purchase 2,500,000 shares of the Company’s common stock, with an original exercise price of $1.25 per share. These warrants are subject to certain anti-dilution rights for issuances below the exercise price; provided that absent shareholder approval, the exercise price may not be reduced to less than $1.08 per share (Class G warrants). These warrants are not registered and cannot be traded. The Class G warrants are exercisable at $1.25 per share at September 30, 2010 as the Company has received a one time waiver for the Class G anti-dilution provision relating to the triggering event which occurred on April 22, 2010 (Class I Warrants). The Company has determined the warrant provisions providing for protection for issuances below the warrant exercise price could result in modification of the exercise price based on a variable that is not an input to the fair value for a fixed-for-fixed option. The Company has determined that the warrants issued in connection with this financing are a derivative instrument which is required to be shown as a derivative liability subject to mark-to-market adjustment each reporting period. At December 31, 2009, the fair value of the warrants was determined using a Black-Scholes model with the following assumptions: risk-free interest rate of 2.35%; no dividend yield; volatility of 98.6% resulting in a derivative liability of approximately $1,063,200. The liability was revalued as of September 30, 2010 using a Black-Scholes model and the following assumptions: risk-free interest rate of 1.27%; no dividend yield; and volatility of 122.3%, resulting in a revalued liability of approximately $715,000 and a derivative gain of approximately $327,000 and $348,000, on the consolidated statements of operations for the three and nine month periods ended September 30, 2010, respectively.
     On April 22, 2010, in connection with common stock issued pursuant to a financing agreement on that date, an investor received a five-year warrant to purchase 1,163,362 shares of the Company’s common stock, with an original exercise price of $1.06 per share, subject to certain anti-dilution rights for issuances below such exercise price (Class I warrants). These warrants are not registered and cannot be traded. The Class I warrants are exercisable one year from the date of issuance. The Company has determined that the warrant provisions providing for protection for issuances below the warrant exercise price could result in modification of the exercise price based on a variable that is not an input to the fair value for a fixed-for-fixed option. The Company has determined the warrants issued in connection with this financing are a derivative instrument which is subject to mark-to-market adjustment each reporting period. At April 22, 2010, the fair value of the warrants was determined to be approximately $968,000. At September 30, 2010, the fair value of the warrants was determined using a Black-Scholes model with the following assumptions: risk-free interest rate of 1.27%; no dividend yield; and volatility of 122.3% resulting in a derivative liability of approximately $360,000 and a derivative gain of approximately $162,000 and $608,000, on the consolidated statements of operations for the three and nine month periods ended September 30, 2010, respectively (also see Note 8).
NOTE 8 — OWNERS’ EQUITY (DEFICIT)
     On March 17, 2010, the Company granted 165,000 shares of common stock to a consultant who provided investor relations consulting services to the Company. The grant was measured using the closing price of the Company’s stock on the date of grant. The statements of operations includes a charge of $160,050 for the nine months ended September 30, 2010 related to this grant, which was credited to common stock and additional paid-in capital.
     On April 22, 2010, Converted Organics Inc. entered into a Securities Purchase Agreement with a single institutional investor. Pursuant to the Securities Purchase Agreement, the Company agreed to issue to the investor: (a) 2,400,000 shares of its common stock at $1.06 per share and (b) five-year warrants to purchase 1,163,362 shares of its common stock at an exercise price of $1.06 per share (Class I Warrants). The warrants may be exercised at any time on or following a date one year after the date of issuance and will expire five years from the date of issuance. The transaction provided the Company with net proceeds of approximately $2.4 million.
     On June 30, 2010, the Company’s stockholders approved the amendment to the Company’s Certificate of Incorporation to increase the number of shares of common stock that the Company is authorized to issue from 75,000,000 shares to 250,000,000 shares.

12


Table of Contents

CONVERTED ORGANICS INC.
NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS —
CONTINUED
(UNAUDITED)
NOTE 8 — OWNERS’ EQUITY (DEFICIT) (Continued)
     On July 19, 2010, the Company issued 1,623,333 shares of its common stock and warrants (Class J Warrants) to acquire 1,623,333 shares of common stock to Atlas Advisors, LLC (“Atlas”). The warrants will expire five years from the date of issuance and have a strike price of $0.54 per share. The issuance to Atlas was made pursuant to an agreement between the parties regarding payments due to Atlas pursuant to a Business Development Agreement dated January 29, 2010. Under the Business Development Agreement, the Company had agreed to compensate Atlas in the event of any mergers and/or acquisitions that were a result of the services provided by Atlas, such payment was to have included both cash payments and equity payments. Pursuant to the agreement reached between the parties, in exchange for the equity consideration listed herein, Atlas agreed that no further consideration be paid to it in connection with the Company’s proposed acquisition of TerraSphere Systems, LLC. The stock and warrant payment was made to Atlas at a share price of $0.54, which was the closing price of the Company’s common stock on the date of the TerraSphere acquisition agreement. The warrants issued to Atlas were issued at an exercise price equal to the price at which the common shares were issued.
The Company issued 320,830 shares of its common stock related to its restructuring during the quarter ended September 30, 2010. The statements of operations includes a charge of approximately $190,000 for the nine months ended September 30, 2010, which was credited to common stock and additional paid-in capital.
     On August 30, 2010, the Company issued 1,157,407 shares of its common stock and warrants (Class K Warrants) to acquire 1,157,407 shares of common stock to Atlas. The warrants will expire five years from the date of issuance and have a strike price of $0.54. The issuance to Atlas was made as consideration for the termination of a Business Development Agreement dated January 29, 2010 by and between the Company and Atlas.
The following table sets forth the outstanding warrants as of September 30, 2010:
                                                                                 
    Class B Warrants     Class C Warrants     Class D Warrants     Class E Warrants     Class F Warrants     Class G Warrants     Class H Warrants     Class I Warrants     Class J Warrants     Class K Warrants  
    Exercise Price     Exercise Price     Exercise Price     Exercise Price     Exercise Price     Exercise Price     Exercise Price     Exercise Price     Exercise Price     Exercise Price  
    $11.00     $1.00     $1.02     $1.63     $1.25     $1.25     $1.30     $1.06     $0.54     $0.54  
Outstanding at 12/31/09
    4,932,438       885,000       415,000       1,500,000       585,000       2,500,000       17,250,000                    
Issued
                                              1,163,362       1,623,333       1,157,407  
Exercised
                                                           
Canceled
                                                           
 
                                                           
Outstanding at 09/30/10
    4,932,438       885,000       415,000       1,500,000       585,000       2,500,000       17,250,000       1,163,362       1,623,333       1,157,407  
 
                                                           
Exercisable at 09/30/10
    4,932,438       885,000       415,000       1,500,000       585,000       2,500,000       17,250,000       1,163,362       1,623,333       1,157,407  
 
                                                           
On October 18, 2010, 2,284,409 Class B warrants were retired by the Bond holder (see Note 12).
NOTE 9 — FAIR VALUE MEASUREMENTS
     The Company applies Financial Accounting Standards Board’s Accounting Standard Codification, Topic 820 Fair Value Measurement and Disclosures (ASC 820), which defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements.
     ASC 820 emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

13


Table of Contents

CONVERTED ORGANICS INC.
NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS — CONTINUED

(UNAUDITED)
NOTE 9 — FAIR VALUE MEASUREMENTS (Continued)
     Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.
     The Company’s liabilities that are reported at fair value in the accompanying consolidated balance sheets as of September 30, 2010 and December 31, 2009 were as follows:
                         
            Balance  
    Level of Hierarchy     September 30, 2010     December 31, 2009  
Derivative liabilities
  Level 3   $ 1,434,127     $ 1,626,742  
     The following table reflects the change in Level 3 fair value of the Company’s derivative liabilities for the three and nine month periods ended September 30, 2010:
                 
    Three months ended     Nine months ended  
Balance, beginning of period
  $ 2,096,109     $ 1,626,742  
Fair value of derivatives issued
          968,096  
Derivative (gain) loss
    (661,982 )     (1,160,711 )
 
           
Balance, end of period
  $ 1,434,127     $ 1,434,127  
 
           
     The Company has other non-derivative financial instruments, such as cash, accounts receivable, accounts payable, accrued expenses and long-term debt, for which the carrying amounts approximate fair value.
NOTE 10 — STOCK OPTION PLAN
     The following table presents the activity under the 2006 Stock Option Plan from January 1, 2010 through September 30, 2010:
                 
    Options Outstanding     Price Per Share  
Outstanding at December 31, 2009
    1,230,295     $ 3.54  
Granted
    2,508,500       .68  
Exercised
    (50,000 )     .97  
Canceled
           
 
           
Outstanding at September 30, 2010
    3,688,795     $ 1.63  
 
           
 
               
Exercisable at September 30, 2010
    3,638,795     $ 1.63  
 
           
     The expense associated with granting these options was calculated using a Black-Scholes model. The resulting expense of the above options granted was $6,660 and $1,305,812 for the three and nine month periods ended September 30, 2010, respectively, and is included in general and administrative expense on the consolidated statements of operations. As of September 30, 2010, there was unrecognized compensation cost of approximately $4,000 related to non-vested share-based compensation arrangements granted under the Company’s stock option plan. There was no intrinsic value of the Company’s outstanding stock options at September 30, 2010.

14


Table of Contents

CONVERTED ORGANICS INC.
NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS — CONTINUED

(UNAUDITED)
NOTE 11 —COMMITMENTS AND CONTINGENCIES
LEASE COMMITMENTS
     The Company’s future minimum lease payments are as follows:
         
Years ending December 31, 2010 (October 1, 2010 through December 31, 2010)
  $ 85,459  
2011
    344,988  
2012
    338,748  
2013
    234,898  
2014
    238,645  
2015 and thereafter
    1,924,633  
 
     
 
  $ 3,167,371  
 
     
     The Woodbridge facility future minimum lease payments have been excluded from the above table (See Note 12).
LEGAL PROCEEDINGS
     The Company is not currently aware of any pending or threatened legal proceeding to which it is or would be a party, or any proceedings being contemplated by governmental authorities against it, or any of its executive officers or directors relating to the services performed on the Company’s behalf except as follows.
     On December 11, 2008, the Company received notice that a complaint had been filed in a putative class action lawsuit on behalf of 59 persons or entities that purchased units pursuant to a financing terms agreement, or FTA, dated April 11, 2006, captioned Gerald S. Leeseberg, et al. v. Converted Organics, Inc., filed in the U.S. District Court for the District of Delaware. The lawsuit alleges breach of contract, conversion, unjust enrichment, and breach of the implied covenant of good faith in connection with the alleged failure to register certain securities issued in the FTA, and the redemption of the Company’s Class A warrants in November 2008. The lawsuit seeks damages related to the failure to register certain securities, including alleged late fee payments, of approximately $5.25 million, and unspecified damages related to the redemption of the Class A warrants. In February 2009, the Company filed a Motion for Partial Dismissal of Complaint. On October 7, 2009, the Court concluded that Leeseberg has properly stated a claim for actual damages resulting from the Company’s alleged breach of contract, but that Leeseberg has failed to state claims for conversion, unjust enrichment and breach of the implied covenant of good faith, and the Court dismissed such claims. On November 6, 2009, the Company filed its answer to the Complaint with the Court. On March 4, 2010, the parties participated in a conference, and began discussing discovery issues. Plaintiff filed a Motion for Class Certification on June 22, 2010, which is pending before the District Court. A jury trial has been set for May 17, 2011. The Company plans to vigorously defend this matter and is unable to estimate any losses that may or may not be incurred as a result of this litigation and its eventual disposition. Accordingly, no loss has been recorded related to this matter.
     Related to the above matter, in December 2009, the Company filed a complaint in the Superior Court of Massachusetts for the County of Suffolk, captioned Converted Organics Inc. v. Holland & Knight LLP. The Company claims that in the event it is required to pay any monies to Mr. Leeseberg and his proposed class in the matter of Gerald S. Leeseberg, et al. v. Converted Organics, Inc., that Holland & Knight should make the Company whole, because its handling of the registration of the securities at issue in the Leeseberg lawsuit caused any loss that Mr. Leeseberg and other putative class members claim to have suffered. Holland & Knight has not yet responded to the complaint. Holland and Knight has threatened to bring counterclaims against Converted Organics for legal fees allegedly owed, which we would contest vigorously. On May 12, 2010, the Superior Court stayed the proceedings, pending resolution of the Leeseberg litigation. At this early stage in the case, the Company is unable to predict the likelihood of an unfavorable outcome, or estimate any loss/gain.

15


Table of Contents

CONVERTED ORGANICS INC.
NOTES TO CONSOLIDATED INTERIM FINANCIAL STATEMENTS — CONTINUED

(UNAUDITED)
NOTE 11 —COMMITMENTS AND CONTINGENCIES (Continued)
LEGAL PROCEEDINGS (Continued)
     On May 19, 2009, the Company received notice that a complaint had been filed in the Middlesex County Superior Court of New Jersey, captioned Lefcourt Associates, Ltd. v. Converted Organics of Woodbridge, et al. The lawsuit alleged private and public nuisances, negligence, continuing trespasses and consumer common-law fraud in connection with the odors emanating from the Woodbridge facility and its alleged, intentional failure to disclose to adjacent property owners the possibility of the facility causing pollution and was later amended to allege adverse possession, acquiescence and easement. The lawsuit sought enjoinment of any and all operations which in any way cause or contribute to the alleged pollution, compensatory and punitive damages, counsel fees and costs of suit and any and all other relief the Court deems equitable and just. On April 12, 2010, the Middlesex County Superior Court of New Jersey issued an administrative order settlement dismissing without prejudice the matter of Lefcourt Associates, Ltd. v. Converted Organics of Woodbridge, et al. On June 8, 2010, Lefcourt Associates, Ltd re-filed their lawsuit but before a different court, the Chancery Division in Bergen County. The Company filed a motion to transfer the action back to the original court in Middlesex County, which was granted and sought to have the lawsuit dismissed, which was granted in part on August 27, 2010. The Court limited the plaintiffs claims to the events in part that occurred after the dismissal of the prior action.
NOTE 12 — SUBSEQUENT EVENTS
WOODBRIDGE TRANSACTION
     On October 18, 2010, Converted Organics Inc. entered into an Exchange Agreement (the “Exchange Agreement”) with the sole Bond Holder of $17,500,000 New Jersey Economic Development Authority Bonds (the “Bonds”) that were issued on behalf of Woodbridge. Pursuant to the Exchange Agreement, the Bond Holder agreed to exchange: (i) the Bonds (which represented 100% of all Bonds), and (ii) class B warrants to purchase 2,284,409 shares the Company’s common stock (the “Class B Warrants”) for 17,500 shares of the Company’s newly authorized 1% Series A Convertible Preferred Stock (the “Series A Preferred Stock”). In addition, the Bond Holder agreed to waive all interest accrued and unpaid from February 1, 2010 until the date of the Exchange Agreement on the Bonds, and agreed to transfer to the Company approximately $600,000 that the Company had previously deposited into certain reserve accounts in connection with the Bonds.
     The Series A Preferred Stock is convertible into the number of shares of Common Stock equal to (1) the stated value of the share ($1,000), divided by (2) $0.543 (the “Conversion Price”). Holders of the Series A Preferred are entitled to receive cumulative dividends at the rate per share (as a percentage of the stated value per share) of 1% per annum (subject to increase in certain circumstances), payable annually and on each conversion date. The dividends are payable, during the first three years after issuance, at the election of the Company, and thereafter, at the election of the holder, in cash or in shares of Company common stock valued at the Conversion Price (or in some combination thereof).
     On October 18, 2010, the Company and the Woodbridge Facility’s landlord (“Lessor”) entered into a Termination and Surrender Agreement (“Termination Agreement”) related to the termination of the Woodbridge Facility lease. Under the lease, there were approximately $9.1 million of future rental payments. In addition, the Lessor asserted claims for (i) unpaid sewer and trash removal charges; (ii) unpaid rent due Lessor for prior periods; (iii) certain costs and expenses incurred by Lessor in connection with certain litigation; (iv) damages that may result from the condition of the premises at the time of surrender; and (v) the required removal and disposal of abandoned inventory and materials totaling approximately $1,500,000. Pursuant to the Termination Agreement, the Lessor and the Company agreed to terminate the lease surrendering the premises and transferring all equipment, tools and fixtures owned by the Company and presently located at the premises. Pursuant to the terms of the Termination Agreement, the Company agreed to issue the Lessor a total of 892,857 shares of Company common stock valued at $0.56 per share. In addition, the Company has deposits totaling $415,000 with the Lessor which will not be returned to the Company.
     On October 18, 2010, the Superior Court of the State of California for the County of Los Angeles entered an Order in the matter entitled American Capital Management, LLC (“ACM”) v. Converted Organics Inc. and Converted Organics of Woodbridge, LLC and Does 1-10 Inclusive (the “Order”). The Order provides for the full and final settlement of $11.3 million of claims against the Company held by ACM. The claims include the future rental payments discussed above, which were acquired by ACM from the Lessor, as well as the acquisition of approximately $1.7 million of promissory notes issued by the Company to four contractors that had provided services to the Woodbridge Facility. ACM purchased the claims from these parties pursuant to separate claims purchase agreements. Pursuant to the terms of the Order, the Company agreed to issue to ACM a total of 20,726,980 shares of Company common stock valued at $0.543 per share in full and final settlement of the claims.

16